CiltEnoxaparin for Outpatients with COVID-19: 90-day Results from the Randomised, Open-label, Parallel-group, Multinational, Phase III OVID TrialDavide Voci, Andrea Götschi, Ulrike Held, Roland Bingisser, Giuseppe Colucci, Daniel Frank Dürschmied, Riccardo M. Fumagalli, Bernhard Gerber, Barbara Hasse, Dagmar I. Keller, Stavros Konstantinides, François Mach, Silvana K. Rampini, Marc Righini, Helia Robert-Ebadi, Thomas Rosemann, Stéphanie Roth-Zetzsche, Tim Sebastian, Noemi R. Simon, David Spirk, Stefan Stortecky, Lukas Vaisnora, Nils Kucher, Stefano Barco